Senior Counsels Jason Drori and Simon Elliott contributed an article to IPPro Patents, “The PRICED Act: A Bold Attempt to Change the Biologics Market,” on August 17, 2016. The article examined the Price Relief, Innovation, and Competition for Essential Drugs (PRICED) Act proposed legislation that aims to reduce the market exclusivity period for new biologics from 12 to seven years in the United States. Drori and Elliott discussed how the PRICED Act may be a more direct threat to the biologics industry and risks upsetting a delicate balance.
Related Insights
14 March 2025
Manufacturing Industry Advisor
Brainwaves: 100 Days and Beyond | Presidential Policy Shifts Impacting Automotive
In a recent Brainwaves event hosted by the Society of Automotive Analysts and Foley & Lardner LLP, titled “100 Days and Beyond: Presidential Policy Shifts Impacting Automotive,” business and legal executives gathered in Detroit to discuss the significant shifts in presidential policies and their profound impact on the automotive sector.
23 April 2025
Events
Rooftop Reception at IAPP Global Privacy Summit 2025
Following the first day of the International Association of Privacy Professionals’ 2025 Global Privacy Summit, Foley & Lardner’s Cybersecurity & Data Privacy team will be hosting a networking reception on the rooftop of The Delegate, conveniently located across the street from the venue.
13 March 2025
Foley Ignite
New Opportunities and Challenges for Board Directors
Foley & Lardner LLP recently co-hosted a webinar with the National Association of Corporate Directors to discuss how a new presidential administration and evolving state-driven regulations are effecting boardrooms.